HIV infection is associated with diffusing capacity impairment in women
about
HIV and noncommunicable cardiovascular and pulmonary diseases in low- and middle-income countries in the ART era: what we know and best directions for future researchLung function abnormalities in HIV-infected adults and childrenFactors associated with abnormal spirometry among HIV-infected individualsHIV-associated obstructive lung diseases: insights and implications for the clinician.Pulmonary Function in HIV-Infected Recreational Drug Users in the Era of Anti-Retroviral TherapyRelationships of pulmonary function, inflammation, and T-cell activation and senescence in an HIV-infected cohortTopographic diversity of the respiratory tract mycobiome and alteration in HIV and lung diseaseCorrelation of the lung microbiota with metabolic profiles in bronchoalveolar lavage fluid in HIV infectionObstructive Lung Diseases in HIV: A Clinical Review and Identification of Key Future Research Needs.Widespread activation of immunity and pro-inflammatory programs in peripheral blood leukocytes of HIV-infected patients with impaired lung gas exchange.Novel relationships of markers of monocyte activation and endothelial dysfunction with pulmonary dysfunction in HIV-infected persons.Respiratory symptoms in people living with HIV and the effect of antiretroviral therapy: a systematic review and meta-analysis.Non-infectious pulmonary disorders in HIV.Use of rosuvastatin in HIV-associated chronic obstructive pulmonary disease.Respiratory health status is impaired in UK HIV-positive adults with virologically suppressed HIV infection.Decreased Lung Function and All-cause Mortality in HIV-Infected Individuals.Pulmonary disease in HIV-infected adults in the era of antiretroviral therapy.
P2860
Q26827746-40419158-2D25-4541-B9FA-89D7FD848056Q26863389-DB3BBF77-DEA7-432C-AAAA-0E7D00D52B15Q28388780-636B34C6-390F-4C56-9082-E7E9D16AA263Q33950594-F9744F2A-25E2-4A0A-9FAA-581163CDFA7FQ35053051-5EAF69EC-0DC6-45DA-BCD5-D168EFC51748Q35493901-B38EBC1A-F895-46DD-BA64-E2C42927B994Q35618488-EF3890B8-F361-48C8-BCFB-FDD336A9324FQ35899601-31C39279-B0DA-490A-A591-E324D4AC31BEQ36733646-FDC22208-59AE-4352-85D9-CC6BA8FE6CE1Q36846440-457C5BBC-3AA9-4A1B-BC09-D44E35A6C593Q37102014-DAED2AE7-59ED-4754-845C-710658BBC9FEQ39037971-011EE328-B15A-42EF-89AC-ADD345A6E967Q39106214-58097136-BF56-42B9-8D84-84585F0836E9Q39110774-04DE4CD1-8072-4846-ABC1-F58BB9C7934CQ40292019-9D454478-DD6B-46E3-A514-C39DF58C07ABQ47192174-99649591-F4A4-4C4C-82B0-31540876CA9DQ47693953-5941A1D9-20B2-4748-84F4-EFC4CF0F5CD0
P2860
HIV infection is associated with diffusing capacity impairment in women
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
HIV infection is associated with diffusing capacity impairment in women
@en
HIV infection is associated with diffusing capacity impairment in women.
@nl
type
label
HIV infection is associated with diffusing capacity impairment in women
@en
HIV infection is associated with diffusing capacity impairment in women.
@nl
prefLabel
HIV infection is associated with diffusing capacity impairment in women
@en
HIV infection is associated with diffusing capacity impairment in women.
@nl
P2093
P2860
P1476
HIV infection is associated with diffusing capacity impairment in women
@en
P2093
Alison Morris
Cathy Kessinger
Claudia Ponath
David Claman
Eric Kleerup
Laurence Huang
Lorrie Lucht
Matthew R Gingo
Meghan E Fitzpatrick
Ruth M Greenblatt
P2860
P304
P356
10.1097/QAI.0B013E3182A9213A
P407
P577
2013-11-01T00:00:00Z